Shares of Zoetis (NYSE:ZTS) traded lower on Tuesday after the U.S. FDA notified veterinarians about adverse events linked to the company’s pain therapy, Librela (bedinvetmab injection ...
Some results have been hidden because they may be inaccessible to you